Common Side Effects of Fosamax
Fosamax (alendronate), a bisphosphonate for osteoporosis, most often causes gastrointestinal issues like abdominal pain, nausea, dyspepsia, constipation, diarrhea, and musculoskeletal pain. Esophageal irritation or ulcers occur if not taken properly (e.g., upright with water).[1][2]
Rare Side Effects Patients Report
Less than 1% of users experience:
- Ocular issues: Scleritis, uveitis, or blurred vision.
- Skin reactions: Photosensitivity, rash, or Stevens-Johnson syndrome.
- Neurologic effects: Vertigo or transient symptoms mimicking transient ischemic attacks.
These appear in post-marketing reports and may resolve after stopping the drug.[1][3]
Serious Rare Risks Like Osteonecrosis of the Jaw (ONJ)
ONJ, jaw bone death, affects about 1 in 10,000 to 1 in 100,000 patients yearly, mainly after dental procedures or in cancer patients on higher doses. Risk factors include poor oral hygiene, smoking, or long-term use (>4 years).[1][2][4]
Atypical Femur Fractures
Subtrochanteric or femoral shaft fractures occur rarely (3-50 cases per 100,000 patient-years) after 3+ years of use. Symptoms include thigh/groin pain before complete fracture. FDA added warnings in 2010; risk drops after discontinuation.[1][5]
How Long Do Risks Last After Stopping?
Bisphosphonates like Fosamax linger in bone for years, so atypical fractures or ONJ risks persist 1-3 years post-use. Guidelines recommend drug holidays after 3-5 years for low-risk patients.[2][6]
Who Gets These Rare Effects?
Higher incidence in those with dental disease, chemotherapy, corticosteroids, or diabetes. Oral Fosamax has lower ONJ risk than IV bisphosphonates. Monitor via dental checks before starting.[1][4]
Alternatives If Worried About Rare Risks